Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. - Pawlyn C; Schjesvold FH; Cairns DA; Wei LJ; Davies F; Nadeem O; Abdulhaq H; Mateos MV; Laubach J; Weisel K; Ludwig H; Rajkumar SV; et al. (Blood cancer journal, 2024)